Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Risedronate sodium
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Risedronate sodium 35mg tablets
0606020R0AAADAD
|
Risedronate sodium | Risedronate sodium | Endocrine System | 199,949 |
|
Risedronate sodium 5mg tablets
0606020R0AAAAAA
|
Risedronate sodium | Risedronate sodium | Endocrine System | 6,321 |
|
Risedronate sodium 30mg tablets
0606020R0AAABAB
|
Risedronate sodium | Risedronate sodium | Endocrine System | 173 |
|
Risedronate sodium 35mg/5ml oral liquid
0606020R0AAAEAE
|
Risedronate sodium | Risedronate sodium | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.